7.54MMarket Cap
LossP/E TTM
AEON Financials
See Aeon Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Aeon Biopharma Inc Earnings Date
Latest Release
May 14, 2026
Analyst Rating
BUY
2026/07/31
FAQs
What are the current assets of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its current assets were 6.62M, with a year-on-year change of 94.97.
What are the total assets of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total assets of Aeon Biopharma Inc were 8.63M, with a year-on-year change of 55.22.
What are the total liabilities of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total liabilities of Aeon Biopharma Inc were 25.38M, with a year-on-year change of -58.11.
What is the total equity of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its total equity of Aeon Biopharma Inc was -16.75M, with a year-on-year change of 69.56.
What is the net operating income of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its net operating income of Aeon Biopharma Inc was -5.93M, with a year-on-year change of 63.61.
What is the net financing of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its net financing of Aeon Biopharma Inc was 20.30M, with a year-on-year change of 34.05.
What is the Earnings Per Share (EPS) of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -0.29, with a year-on-year change of 92.66.
What is the debt-to-asset ratio of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its debt-to-asset ratio was 17.87, with a year-on-year change of -97.13.
What is the operating profit of Aeon Biopharma Inc?
According to Aeon Biopharma Inc's FY2026 earnings report, its operating profit was -5.93M, with a year-on-year change of 63.61.